-
Adherence
-
Children
-
Clinical reviews
-
Drug supply
-
Guidelines
-
Hepatitis and HIV coinfection
-
HIV Testing
-
Infant feeding
-
Laboratory monitoring
-
Malaria & HIV
-
Mental health and HIV
-
Neurological problems, including HIV dementia
-
Nutrition
-
Palliative care
-
Prevention
-
Prevention of mother-to child transmission
-
Scaling up treatment and models of service delivery
-
Side-effects
-
South Africa
-
Starting treatment
-
Stigma
-
Task shifting
-
Treatment failure
-
Tuberculosis
- Catalysing HIV/TB research: a meeting report
- HIV and TB in Practice: encouraging data on IPT - 09/07/09
- Unprecedented focus on TB at HIV Implementers' Meeting - 09/07/09
- HIV and TB in Practice - 21/05/09
- HIV and TB in Practice - 23/04/09
- TB research is research to save the lives of people with HIV, 5/2/09
- Childhood TB (part 3): treatment and prevention
- Childhood TB (part 2): presentation and diagnosis
- Childhood TB (part 1)
- Improving HIV diagnosis in TB patients: new approaches bearing fruit (24/7/08)
- Getting the formula right to deliver HIV services, including ART, to TB patients with HIV (24/7/08)
- Three I's to reduce the burden of TB in people with HIV (26/6/08)
- Recommendations on Three I's implementation (26/6/08)
- Our health facilities are still unsafe: why we all need to do something about TB infection control (29/5/08)
- Expert views on TB infection control measures (29/5/08)
- Intensified case finding: developing an action plan - 12/3/2008
- Think TB in people with HIV: start routinely screening for TB now - 12/3/2008
- Treating MDR TB in the community: what are the challenges? (17/1/08)
- Isoniazid preventive therapy for TB in people with HIV: barriers to national implementation - 29/11/2007
- Time for clear and simple messages about delivering isoniazid preventive therapy (IPT) - 30/11/2007
- Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment - 30/11/2007
- It’s time to integrate TB/HIV care on a national scale - 17/7/2007
- TB transmission in healthcare settings and improving infection control - 19/12/2006
- Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now - 28/11/2006
- Expanding beyond DOTS to stop TB - 31/3/2006
- Improving the diagnosis of active TB in people with HIV - 19/3/2006
- Isoniazid preventative therapy - 19/3/2006
- HIV/AIDS treatment activists welcomed at World Tuberculosis (TB) Meeting but is the TB world ready for everything they have to say? - 19/3/2006
- HIV's impact on TB control: is it time to re-think TB control strategies? - 27/10/2005
- An Integrated Approach to HIV and TB Care in Adults in Resource-Limited Settings - Part 1 - 27/10/2005
- Isoniazid prophylaxis treatment for children with HIV: is it ready for implementation? - 27/10/2005
- Treating latent TB - 27/10/2005
-
Viral load testing
feedback
Give us your views on our work
Tuberculosis
-
Catalysing HIV/TB research: a meeting report
-
HIV and TB in Practice: encouraging data on IPT - 09/07/09
-
Unprecedented focus on TB at HIV Implementers' Meeting - 09/07/09
-
HIV and TB in Practice - 21/05/09
-
HIV and TB in Practice - 23/04/09
-
TB research is research to save the lives of people with HIV, 5/2/09
-
Childhood TB (part 3): treatment and prevention
-
Childhood TB (part 2): presentation and diagnosis
-
Childhood TB (part 1)
-
Improving HIV diagnosis in TB patients: new approaches bearing fruit (24/7/08)
-
Getting the formula right to deliver HIV services, including ART, to TB patients with HIV (24/7/08)
-
Three I's to reduce the burden of TB in people with HIV (26/6/08)
-
Recommendations on Three I's implementation (26/6/08)
-
Our health facilities are still unsafe: why we all need to do something about TB infection control (29/5/08)
-
Expert views on TB infection control measures (29/5/08)
-
Intensified case finding: developing an action plan - 12/3/2008
-
Think TB in people with HIV: start routinely screening for TB now - 12/3/2008
-
Treating MDR TB in the community: what are the challenges? (17/1/08)
-
Isoniazid preventive therapy for TB in people with HIV: barriers to national implementation - 29/11/2007
-
Time for clear and simple messages about delivering isoniazid preventive therapy (IPT) - 30/11/2007
-
Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment - 30/11/2007
-
It’s time to integrate TB/HIV care on a national scale - 17/7/2007
-
TB transmission in healthcare settings and improving infection control - 19/12/2006
-
Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now - 28/11/2006
-
Expanding beyond DOTS to stop TB - 31/3/2006
-
Improving the diagnosis of active TB in people with HIV - 19/3/2006
-
Isoniazid preventative therapy - 19/3/2006
-
HIV/AIDS treatment activists welcomed at World Tuberculosis (TB) Meeting but is the TB world ready for everything they have to say? - 19/3/2006
-
HIV's impact on TB control: is it time to re-think TB control strategies? - 27/10/2005
-
An Integrated Approach to HIV and TB Care in Adults in Resource-Limited Settings - Part 1 - 27/10/2005
-
Isoniazid prophylaxis treatment for children with HIV: is it ready for implementation? - 27/10/2005
-
Treating latent TB - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- GSK and Pfizer launch joint HIV venture, ViiV Healthcare
- New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection
- President Obama announces US HIV travel ban will end in January 2010
- Darunavir/ritonavir, etravirine and raltegravir combination has 'remarkable' success in children with resistant virus
- Retention in opioid replacement programmes improves chances of HIV treatment working for drug users
- High prevalence of anal chlamydia in Swiss HIV-positive gay men
- Cost-effective ways to reduce loss to follow-up in ART programmes identified
- Nurse prescribing of ARVs: evidence of success in Rwanda and Lesotho
- Russia urged to expand prevention for injecting drug users
- CDC approves the removal of US HIV travel ban